Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT vs IMRT with EP in Limited-Stage SCLC
NCT02738723Phase 2Unknown
- Sponsor
- Army Medical University
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in small cell lung cancer (SCLC), sponsored by Army Medical University. Primary endpoint: Progression-Free Survival at 3 years. Status: unknown.
02
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02738723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738723.